Zykadia – Ceritinib uses, dose and side effects
Zykadia is a cancer medicine, which contains the active substance ceritinib. It is used to treat adults with advanced stages of a form of lung cancer called non- small cell lung cancer (NSCLC). Zykadia is only given to patients whose disease is caused by a defect in a gene called ALK (anaplastic lymphoma kinase).
Read More